Explorer
Advertisement
Subject Expert Committee
India
Bharat Biotech Asked For More Data By DCGI For Authorising Covaxin To Children Under 12
India
SII's Covovax Gets Emergency Approval For Children Aged 12-17 Years
India
Biological E Applies For EUA For Covid-19 Vaccine Corbevax For 5-12 Age Group: Report
India
Coronavirus HIGHLIGHTS | Subject Expert Committee Recommends Sputnik Light One-Shot Vaccine: Report
Health
Amid Omicron Fear, Expert Committee Gives No Recommendations For COVID Booster Dose: Report
Health
Omicron Scare: Subject Expert Committee To Hold Meeting Tomorrow Over Booster Doses
India
CDSCO Expert Panel Recommends Emergency Use Of Covaxin For Children Aged Between 2-18
Health
Bharat Biotech Gets Approval To Start Next Phase Of Clinical Trials Of 'Covaxin' On Children Aged 2-18 Years
India
Expert Panel Gives Nod To Bharat Biotech’s Covaxin For Restricted Emergency Use
Short Videos
Advertisement
Advertisement
Advertisement
Top Headlines
India
Celebrities
India
Cities
Advertisement